In view of the many effects shown by leptin on PC chemoresistance, cancer stem cells and Notch and RBP-Jk signaling, we speculate that the inhibition of leptin signaling might be a new strategy to sensitize PC to chemotherapeutics [54]. The gene discussed is LEP; the disease is pachyonychia congenita.